KalVista Pharmaceuticals
KALV
KALV
97 hedge funds and large institutions have $314M invested in KalVista Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $408M → $314M (-$93.8M)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Holders
97
Holding in Top 10
–
Calls
$164K
Puts
$138K
Top Buyers
| 1 | +$15.2M | |
| 2 | +$5.45M | |
| 3 | +$4.63M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.18M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$2.69M |
Top Sellers
| 1 | -$19.9M | |
| 2 | -$13.1M | |
| 3 | -$6.97M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$5.31M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$3.79M |